Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
- PDF / 1,072,314 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 26 Downloads / 188 Views
ORIGINAL RESEARCH
Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment Marcel Slavenburg . Janneke H. van den Bent . Thierry Barten . Margje Reijs-Scheijgrond . Constance de Koning
Received: March 30, 2020 Ó The Author(s) 2020
M. Slavenburg J. H. van den Bent (&) SKIM Rotterdam, Weena 695, B6.036, 3013 AM Rotterdam, The Netherlands e-mail: [email protected]
Methods: A market research study was conducted consisting of two phases: (1) qualitative research (n = 16) in which in-depth interviews were conducted; and (2) quantitative research (n = 101), using a conjoint analysis. Results: Patients reported that the three most important aspects of OAC treatment were (in order of priority) reduced risk of blood clots/ stroke, low bleeding risk, and not having to use a thrombosis service. Only 12% of VKA-treated patients were familiar with DOAC, although 52% were open to switching when presented with a DOAC profile. Conclusions: GPs and patients are waiting for the other to mention issues surrounding AF treatment such as switching, use of thrombosis service, and number of pills to take first. The perceptions and experiences of patients with AF regarding their disease and treatment highly influence the decisions GPs make, together with these patients, as well as considerations that patients have regarding their treatment; GPs need to be aware of their AF patients’ perceptions and experiences with their condition and medication’ in order to facilitate discussions with patients and improve clinical outcomes.
T. Barten M. Reijs-Scheijgrond Pfizer, Rivium Westlaan 142, 2909 LD Capelle a/d IJssel, The Netherlands
Keywords: Anticoagulants; Atrial fibrillation; Disease management
ABSTRACT Introduction: This study was designed to gain insight into the treatment experiences and expectations of patients with atrial fibrillation (AF) who were treated with vitamin K antagonists (VKA) or recently switched from VKA treatment to direct oral anticoagulant (DOAC) therapy. Little is known about the perceptions and expectations of patients with AF who are being prescribed oral anticoagulants (OACs), leading to different expectations of patient and doctor of their respective roles in disease management between the doctor [general practitioner (GP) or cardiologist] and patient on their respective roles in disease management.
Digital features To view digital features for this article go to https://doi.org/10.6084/m9.figshare.12162015.
C. de Koning MedScope, Leeghwaterstraat 19, 2012 GD Haarlem, The Netherlands
Cardiol Ther
Key Summary Points Why carry out this study? The study was designed to gain insight into the treatment experiences and expectations of patients with atrial fibrillation (AF) who were treated with vitamin K antagonists (VKA) or recently switched from VKA treatment to direct oral anticoagulant (DOAC) therapy. What was learned from the study? GPs and patients are waiting for the other to mention issues surrounding AF treatment. The perceptions and e
Data Loading...
